Sionna Therapeutics
(NASDAQ) SION
Sionna Therapeutics Financials at a Glance
Market Cap
$1.80B
Revenue (TTM)
$0.00
Net Income (TTM)
$75.27M
EPS (TTM)
$-1.70
P/E Ratio
-23.63
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Price
$40.08
Volume
2
Open
$37.49
Price
$40.08
Volume
2
Open
$37.49
Previous Close
$40.09
Daily Range
$37.49 - $41.61
52-Week Range
$7.25 - $45.00
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Price
$40.08
Volume
2
Open
$37.49
Previous Close
$40.09
Daily Range
$37.49 - $41.61
52-Week Range
$7.25 - $45.00
SION News
SION: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sionna Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
59
CEO
Michael Cloonan, MBA
Website
www.sionnatx.comHeadquarters
Waltham, MA 02451, US
SION Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-32%
Return on Capital
-28%
Return on Assets
-23%
Earnings Yield
-4.23%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.80B
Shares Outstanding
45.00M
Volume
2
Short Interest
0.00%
Avg. Volume
295.71K
Financials (TTM)
Gross Profit
$647.00K
Operating Income
$88.98M
EBITDA
$88.33M
Operating Cash Flow
$66.30M
Capital Expenditure
$377.00K
Free Cash Flow
$66.67M
Cash & ST Invst.
$235.88M
Total Debt
$8.68M
Sionna Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$152.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$1.80B
N/A
Market Cap/Employee
$44.00M
N/A
Employees
41
N/A
Net Income
$20.44M
-29.0%
EBITDA
$17.94M
+0.1%
Quarterly Fundamentals
Net Cash
$227.21M
+64.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$7.41M
-14.6%
Short Term Debt
$1.27M
+18.4%
Return on Assets
-23.09%
N/A
Return on Invested Capital
-28.32%
N/A
Free Cash Flow
$16.83M
-42.5%
Operating Cash Flow
$16.63M
-41.1%